Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives

Acta Oncologica
Marianne EwertzL Eckhoff

Abstract

Chemotherapy with taxanes and platinum compounds has resulted in substantial survival benefits both in adjuvant and metastatic settings. However, as a side effect, such chemotherapy may cause peripheral neuropathy (CIPN) which may result in discontinuation of treatment, and if it persists after treatment completion, has a negative impact on quality of life (QoL). Symptoms of CIPN are sensory, like pain, numbness, and tingling, typically located in the hands and feet. For oxaliplatin, there is an acute form of CIPN, resulting in paraesthesias in the mouth and throat during or shortly after the infusion triggered by exposure to cold. Risks factors for CIPN include preexisting neuropathy, either from treatment with other neurotoxic agents, or from comorbid conditions. The incidence of CIPN is related to dose per cycle, cumulative dose, and duration of infusion. While cisplatin-induced neuropathy is irreversible, CIPN induced by taxanes may persist for several years in about 30% of patients. Evidence from the literature is suggestive that CIPN is likely to be negatively associated with QoL. No agents have been identified to be recommended for the prevention of CIPN. For treatment of CIPN, the best available data supports a moderate...Continue Reading

References

May 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R W GreggD J Stewart
Nov 27, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G CavalettiG G Etienne
Feb 16, 2002·Journal of Hematotherapy & Stem Cell Research·Angelo VaccaFranco Dammacco
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard H WilsonJean L Grem
Jan 24, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susanna B ParkMatthew C Kiernan
Nov 6, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R K RamanathanT André
Feb 22, 2012·Journal of Neurology·Karima OsmaniNathalie Kubis
Aug 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bryan P SchneiderJoseph A Sparano
Mar 29, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Janet S de MoorJulia H Rowland
Apr 4, 2013·JAMA : the Journal of the American Medical Association·Ellen M Lavoie SmithUNKNOWN Alliance for Clinical Trials in Oncology
Jan 28, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T KrøigårdS H Sindrup
Mar 5, 2014·CA: a Cancer Journal for Clinicians·Susanna B ParkMatthew C Kiernan
Mar 29, 2014·Cancer Management and Research·Andreas A ArgyriouHaralabos P Kalofonos
Apr 16, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dawn L HershmanCharles L Loprinzi
May 3, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Floortje MolsLonneke van de Poll-Franse
May 17, 2014·Cancer Treatment Reviews·N C Miltenburg, W Boogerd

❮ Previous
Next ❯

Citations

Nov 17, 2015·Expert Opinion on Pharmacotherapy·Paola Marmiroli, Guido Cavaletti
Apr 25, 2015·Acta Oncologica·Christoffer Johansen, Susanne Oksbjerg Dalton
Jan 20, 2016·Acta Oncologica·Anja Ør KnudsenUNKNOWN Academy of Geriatric Cancer Research (AgeCare)
Sep 20, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Susana PereiraNuno Lunet
Feb 26, 2016·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·S E CarboneK Nurgali
Dec 25, 2016·British Journal of Pharmacology·Naomi ItoHidenori Suzuki
Feb 17, 2017·Acta Oncologica·Christoffer Johansen, Susanne Oksbjerg Dalton
Jun 22, 2017·Oncology Nursing Forum·Haryani HaryaniYu-Yun Hsu
Sep 28, 2017·Journal of the National Cancer Institute·Hanna BandosPatricia A Ganz
Mar 22, 2018·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Eran Ben-AryeNoah Samuels
Feb 10, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ami TabataToshihiro Kato
Mar 16, 2019·Phytotherapy Research : PTR·Mohammad Reza Ardakani MovaghatiSeyed Hamdollah Mosavat
Jan 6, 2018·Acta Oncologica·Bengt Glimelius
Dec 5, 2017·Continuum : Lifelong Learning in Neurology·Amy A Pruitt
Jul 22, 2015·Current Opinion in Neurology·Guido Cavaletti, Paola Marmiroli
Feb 24, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ying Tsao, Debra K Creedy
Dec 23, 2017·International Journal of Clinical Oncology·Nobuaki HoshinoYoshiharu Sakai
Aug 14, 2020·Molecular Pain·Muhammad Saad YousufBradley J Kerr
Dec 9, 2017·Expert Opinion on Pharmacotherapy·Guido Cavaletti, Paola Marmiroli
Mar 7, 2017·Frontiers in Oncology·Uri HochbergJordi Perez
Jul 1, 2017·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Zhaoxue LuTracy Hammerstrom
Jul 9, 2017·Medical Oncology·Yuko KanbayashiToyoshi Hosokawa
Jun 2, 2018·Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Société Canadienne Pour Le Traitement De La Douleur·Aldric HamaHiroyuki Takamatsu
Jun 7, 2020·Cells·Takahiro DomotoToshinari Minamoto
Jan 1, 2020·Scientific Reports·Chandran RamakrishnaEdouard M Cantin
Nov 28, 2016·International Journal of Colorectal Disease·Nobuaki HoshinoYoshiharu Sakai
Nov 29, 2016·Journal of Pharmaceutical Health Care and Sciences·Junya SatoKenzo Kudo
Aug 6, 2019·BioMed Research International·Yang YangJifeng Feng
Aug 16, 2019·Therapeutic Advances in Medical Oncology·Amber S KlecknerLuke J Peppone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Korean journal of anesthesiology
Hue Jung Park
Current Treatment Options in Oncology
Deirdre R PachmanCharles L Loprinzi
Cancer Treatment Reviews
N C Miltenburg, W Boogerd
The Netherlands Journal of Medicine
Antoinetta J M BeijersGerard Vreugdenhil
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
Andreas A ArgyriouHaralabos P Kalofonos
© 2022 Meta ULC. All rights reserved